Metabolon

05/31/2024

🌍✨ The Metabolon team is on the move! We're thrilled to announce our participation in key events across the globe in June. Catch us in:

🇩🇪 Germany
🇺🇸 California
🇫🇷 France
🇯🇵 Japan
🇳🇱 Netherlands
🇮🇹 Italy
🇨🇭 Switzerland

We're eager to connect with industry leaders, share our latest innovations in metabolomics, and explore new collaborations. Visit our events page for more information and connect with our team to learn how deciphers thousands of discrete chemical signals from genetic and non-genetic factors to discover and reveal biological pathways. Together, let's advance the future of health through and !

📆 https://mtbln.co/qolq5e

05/30/2024

Today on , we join the global community in raising awareness about and celebrating the strength of those living with . Metabolomics research is playing a crucial role in advancing our understanding of MS, and we recently partnered with Cardiff University to advance MS research.

The collaboration aims to uncover novel and pathways associated with MS, providing deeper insights into disease mechanisms and potential therapeutic targets. Metabolomics offers a comprehensive approach to studying MS, allowing for the identification of metabolic signatures indicative of disease progression, treatment response, and patient stratification. By combining Metabolon's expertise in metabolomics with Cardiff University's MS research capabilities, this partnership holds the promise of accelerating breakthroughs in MS diagnosis, management, and treatment. Learn more here: https://bit.ly/3TlTg0i

05/30/2024

NEWS: Metabolon Announces 4-Week Turnaround Time for Commercial Projects, Enhancing Metabolomic Services for Multiomic Research: https://bit.ly/4bZWWMQ

This announcement marks a significant enhancement to our services with a new four-week project turnaround time for Global Discovery Panel projects of up to 2,000 samples, specifically tailored to meet the needs of commercial markets. This is a strategic addition to our recently launched spectral data files and bioinformatics platform offerings, reinforcing the company’s commitment to providing the highest quality and most comprehensive metabolomics solutions in the industry.

05/29/2024

Happy ! Today, we recognize the importance of and the vital role plays in advancing our understanding.

Leveraging our advanced metabolomics technology, we analyze a wide range of to uncover , , and microbial signatures relevant to conditions. Our solutions empower researchers and clinicians to better understand , optimize , and develop targeted interventions for improved digestive wellness. Explore our gastrointestinal solutions here and unlock the potential of metabolomics: https://bit.ly/3RBnxWs

05/28/2024

Check out our latest blog post "Real-Time Assessment of the Brain" which explores the transformative potential of in understanding function and diseases: https://bit.ly/3yxzwQB.

Metabolomics, which involves the comprehensive analysis of small molecules within biological systems, offers a detailed snapshot of states. This capability is particularly valuable in , where real-time monitoring of can reveal critical changes associated with conditions such as , , and . The ability to track these changes dynamically enables more precise diagnosis and better management of disease progression and therapeutic responses.

Further, the integration of metabolomics with other technologies deepens our understanding of brain function and its disorders. Ultimately, these insights could lead to the discovery of novel therapeutic targets and the development of strategies, revolutionizing the field of brain research and improving outcomes for patients with neurological conditions.

Omics technologies do not provide a real-time assessment of the signaling and metabolic pathways in the brain in response to normal and pathological stimuli.

05/23/2024

During , we delve into the complexities of (HBV) infection. Our case study explores the alterations associated with infection, offering insights into the disease mechanisms and potential therapeutic avenues: https://bit.ly/4bB21Lk

Through advanced analysis, we uncover distinct metabolic signatures in HBV-infected individuals, highlighting disruptions in lipid metabolism, amino acid metabolism, and inflammatory pathways. This groundbreaking research, powered by our expertise in metabolomics, contributes to the quest for better diagnostics and treatments for hepatitis B. Let's raise awareness, educate, and support those affected by hepatitis today and every day.

05/22/2024

Leverage Metabolon’s expertly developed and validated methods in any exploratory matrix!

Get immediate access to high-quality, rigorously tested, optimized, and calibrated methodology as the foundations for your study using any sample type.

Learn more about our Exploratory Panels here: https://mtbln.co/mbpakk

05/21/2024

Check out our new blog post, “Metabolomics for Cell and Gene Therapy” by Laura Sommerville, PhD:https://bit.ly/4bLQ4m5.

The blog explores the role of in advancing cell and gene therapies especially critical where understanding cellular can guide the development and optimization of therapeutic strategies. It also highlights that traditional methods often fall short in providing the granularity needed to fully understand the state of cells used in therapies. Metabolomics fills this gap by offering a detailed profile of metabolic changes, thereby enabling better characterization and quality control of therapeutic cells. This approach can improve the efficacy and safety of therapies by ensuring that cells behave as expected once administered to patients.

Furthermore, metabolomics can help identify that predict the success of these therapies, offering a predictive tool for therapeutic outcomes. By integrating metabolomic data with other data, researchers can gain a holistic view of cellular processes, enhancing the precision of cell and gene therapy development.

We examine published studies that demonstrate the payoff that comes from including metabolomics in potency assurance assessments.

05/20/2024

On World Autoimmune and Autoinflammatory Arthritis Day and during , we want to shine a spotlight on and the importance of in finding better treatments. Check out this groundbreaking study that delves into the mechanisms of arthritis and potential therapeutic targets: https://bit.ly/3R9BfC7.

The study investigates the alterations associated with (RA) and (OA) using analysis. Metabolomics, particularly nuclear magnetic resonance spectroscopy, was employed to identify distinct metabolic profiles in the serum of RA and OA patients compared to healthy controls. The findings revealed significant differences in metabolite concentrations, particularly in pathways related to energy metabolism, amino acid metabolism, and lipid metabolism. These metabolic signatures provide insights into the underlying pathophysiological mechanisms of RA and OA, offering potential for disease diagnosis and monitoring.

05/16/2024

🔬 Discover the Future of Metabolomics with Metabolon's Global Discovery Panel! This cutting-edge panel empowers researchers with unparalleled insights into metabolic pathways, enabling breakthroughs in disease research, biomarker discovery, and personalized medicine.

👉 https://mtbln.co/4n05kp

Our Global Discovery Panel provides:

✨ Broad metabolic coverage: Detects and quantifies a vast array of metabolites across multiple biological samples.
🔍 Precision and accuracy: Advanced technology ensures reliable and reproducible results.
🌍 Multiomics Integration: Seamlessly integrate metabolomics with genomics, transcriptomics, and proteomics to gain a holistic view of your biological systems.

Join the forefront of scientific discovery and unlock the potential of your research with Metabolon's Global Discovery Panel. Learn more about how our services can elevate your research here: https://mtbln.co/4n05kp

05/16/2024

NEWS: Metabolon Secures $60 Million Credit Facility to Drive Growth and Innovation

>>> https://bit.ly/3UHgFK1

MORRISVILLE, N.C. – May 16, 2024 – Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, announced that it has closed on a new $60 million credit facility...

05/15/2024

Let's raise awareness about prevention and treatment during . Check out our on-demand webinar on blood-based and how is revolutionizing stroke research: https://bit.ly/44XHGOl

The webinar delves into the transformative role of metabolomics in stroke research, focusing on blood-based biomarkers for enhancing diagnosis and monitoring strategies. Metabolomics, with its ability to capture comprehensive , offers unique insights into the pathophysiology of stroke and the identification of novel biomarkers. The presentation discusses how metabolomics data can be leveraged to differentiate stroke subtypes, predict patient outcomes, and guide approaches. By integrating metabolomics with other technologies and clinical data, researchers can advance our understanding of stroke mechanisms and develop more effective diagnostic and therapeutic interventions, ultimately improving patient care and outcomes.